Interesting look at international coverage of the H1N1 flu story in a new analysis by the Project for Excellence in Journalism.
They studied 12 days of front-page newspaper coverage in seven countries around the world.
Key points from their summary:
The three major U.S. papers studied offered some of the broadest coverage of the outbreak of any country studied, and all stories were staff-generated, as opposed to wire copy. Despite complaints in some quarters of excessive media hype, the level of coverage was relatively moderate when matched up against the number of confirmed U.S. cases.
The number of cases of swine flu in a given country had little to do with the volume of coverage around the world. China, for example, had the fewest confirmed cases of any of the countries studied (1), but the paper studied, People’s Daily, offered about as much front-page coverage as the average paper in the U.S., which had over 2000 cases.
In Mexico, extensive coverage by El Universal (20 front-page stories over the 12 days) cut across a broad range of issues, from the impact on businesses to the history of the virus. But the Mexican paper largely skipped any close assessment of its own government’s response.
The French paper Le Figaro was more restrained but also controversial in its coverage. The paper ran just two stories on the front pages, but sparked an outcry by terming the outbreak “the Mexican flu.”
In the Spanish-language papers in the U.S., one of the most striking findings was a heavy reliance by two of the three—El Diario and El Nuevo Herald—on U.S. wire service copy to fill their pages.
Opinions on other issues in news, journals, PR, advertising, marketing
A great read on this weekend’s NYT claims of a cure for Type 1.
Cure for Type 1 diabetes? We’ve been down this road before with NY Times https://www.healthnewsreview.org/2021/11/cure-for-type-1-diabetes-weve-been-down-this-road-before-with-ny-times/
"But it is the framing and the emphasis of the #journalism by a leading science journalist at a leading newspaper that demands scrutiny. It has an impact on readers and on sick people that may cause harm by promoting false hope about extremely preliminary research"
👍👏💪 truth https://twitter.com/garyschwitzer/status/1465399358137024518
Why we should still miss healthnewsreview. https://twitter.com/garyschwitzer/status/1465399358137024518
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
N95 Flu Respirators
July 27, 2009 at 12:35 pmI’m surprised the level of coverage was moderate compared to the actual amount of cases in the United States. Why with this but not when it comes to plane accident stories (which seem to increase greatly when one crash makes big headlines)?
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like